{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:12:25Z","timestamp":1789477945094,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA HD008989"],"award-info":[{"award-number":["ZIA HD008989"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA HD009001\u201301"],"award-info":[{"award-number":["ZIA HD009001\u201301"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1ZICMH002961"],"award-info":[{"award-number":["1ZICMH002961"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ymgme.2023.107584","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T11:04:35Z","timestamp":1681556675000},"page":"107584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Brain proton MR spectroscopy measurements in CLN3 disease"],"prefix":"10.1016","volume":"139","author":[{"given":"An N.","family":"Dang Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva H.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristan A.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane G.","family":"Soldatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey E.","family":"Thurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ymgme.2023.107584_bb0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying batten disease, CLN3. The international batten disease consortium","volume":"82","year":"1995","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ymgme.2023.107584_bb0010","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","article-title":"The neuronal ceroid-lipofuscinoses: a historical introduction","volume":"1832","author":"Haltia","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.ymgme.2023.107584_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/21678707.2019.1684258","article-title":"Advances in the treatment of neuronal ceroid Lipofuscinosis","volume":"7","author":"Rosenberg","year":"2019","journal-title":"Expert Opin. Orphan. Drugs"},{"issue":"9","key":"10.1016\/j.ymgme.2023.107584_bb0020","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1177\/0883073813494813","article-title":"Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (batten disease)","volume":"28","author":"Adams","year":"2013","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13816810.2016.1210651","article-title":"Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life","volume":"38","author":"Preising","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2023.107584_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12366","article-title":"Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures","author":"Abdennadher","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107584_bb0035","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ajmg.a.62114","article-title":"Characterizing upper limb function in the context of activities of daily living in CLN3 disease","volume":"185","author":"Hildenbrand","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"issue":"12","key":"10.1016\/j.ymgme.2023.107584_bb0040","article-title":"The CLN3 gene and protein: what we know","volume":"7","author":"Mirza","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107584_bb0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","article-title":"Human pathology in NCL","volume":"1832","author":"Anderson","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107584_bb0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s002340050427","article-title":"MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type","volume":"39","author":"Autti","year":"1997","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107584_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pediatrneurol.2013.10.013","article-title":"Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study","volume":"50","author":"Tokola","year":"2014","journal-title":"Pediatr. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107584_bb0065","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00234-022-02988-9","article-title":"Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker","volume":"64","author":"Hochstein","year":"2022","journal-title":"Neuroradiology"},{"issue":"8","key":"10.1016\/j.ymgme.2023.107584_bb0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acn3.222","article-title":"Evaluation of disease progression in INCL by MR spectroscopy","volume":"2","author":"Baker","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107584_bb0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2007-973772","article-title":"Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis","volume":"27","author":"Brockmann","year":"1996","journal-title":"Neuropediatrics"},{"issue":"9","key":"10.1016\/j.ymgme.2023.107584_bb0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid Neurofilament light protein in neurology: a systematic review and Meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"issue":"21","key":"10.1016\/j.ymgme.2023.107584_bb0085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107584_bb0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41436-020-01035-3","article-title":"Neurofilament light chain levels correlate with clinical measures in CLN3 disease","volume":"23","author":"Dang Do","year":"2021","journal-title":"Genet. Med."},{"issue":"20","key":"10.1016\/j.ymgme.2023.107584_bb0095","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1212\/WNL.0b013e318237f649","article-title":"\u201cquantifying physical decline in juvenile neuronal ceroid lipofuscinosis (batten disease),\u201d (in eng)","volume":"77","author":"Kwon","year":"2011","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.ymgme.2023.107584_bb0100","doi-asserted-by":"crossref","first-page":"e2436","DOI":"10.1212\/WNL.0000000000009454","article-title":"The CLN3 disease staging system: a new tool for clinical research in batten disease","volume":"94","author":"Masten","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107584_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.wnl.0000169019.41332.8a","article-title":"A clinical rating scale for batten disease: reliable and relevant for clinical trials","volume":"65","author":"Marshall","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0110","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1212\/WNL.0000000000007773","article-title":"Motor function impairment is an early sign of CLN3 disease","volume":"93","author":"Kuper","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107584_bb0115","series-title":"Wechsler Intelligence Scale for Children\u2013Fifth Edition (WISC-V)","author":"Wechsler","year":"2014"},{"key":"10.1016\/j.ymgme.2023.107584_bb0120","series-title":"WAIS-IV Administration and Scoring Manual (Canadian)","author":"Wechsler","year":"2008"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107584_bb0125","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ajmg.a.62607","article-title":"Use of the Vineland-3, a measure of adaptive functioning, in CLN3","volume":"188","author":"Dang Do","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107584_bb0130","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ymgme.2019.11.014","article-title":"\u201cCross-validation of the Vineland-III with independent assessments of cognition and adaptive skills in CLN3 disease,\u201d (in English)","volume":"129","author":"Adams","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107584_bb0135","first-page":"8","article-title":"Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis","volume":"45","author":"Lamminranta","year":"2001","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.ymgme.2023.107584_bb0140","series-title":"Vineland Adaptive Behavior Scales\u2013Third Edition (Vineland-3)","author":"Sparrow","year":"2016"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107584_bb0145","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jimd.12366","article-title":"Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures","volume":"44","author":"Abdennadher","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107584_bb0150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jmri.21285","article-title":"Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 tesla","volume":"27","author":"Baker","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mrm.10242","article-title":"Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging","volume":"48","author":"Horska","year":"2002","journal-title":"Magn. Reson. Med."},{"issue":"sup1","key":"10.1016\/j.ymgme.2023.107584_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a world beyond \u201cp<0.05\u201d","volume":"73","author":"Wasserstein","year":"2019","journal-title":"Am. Stat."},{"issue":"3\u20135","key":"10.1016\/j.ymgme.2023.107584_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000111347","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells, (in eng)","volume":"15","author":"Brand","year":"1993","journal-title":"Dev. Neurosci."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107584_bb0175","first-page":"1619","article-title":"Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy, (in eng)","volume":"20","author":"Bitsch","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107584_bb0180","first-page":"1373","article-title":"MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Seitz","year":"1998","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"12","key":"10.1016\/j.ymgme.2023.107584_bb0185","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","article-title":"An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder batten disease","volume":"11","author":"Chattopadhyay","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107584_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2990.2006.00738.x","article-title":"Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis","volume":"32","author":"Lim","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymgme.2010.11.164","article-title":"Research challenges in central nervous system manifestations of inborn errors of metabolism","volume":"102","author":"Dickson","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107584_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgme.2016.04.006","article-title":"Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions","volume":"118","author":"Shapiro","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"20","key":"10.1016\/j.ymgme.2023.107584_bb0205","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/01.wnl.0000291557.62706.d3","article-title":"Guidelines for using proton MR spectroscopy in multicenter clinical MS studies","volume":"69","author":"De Stefano","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107584_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1203\/PDR.0b013e3181a27a16","article-title":"Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders","volume":"66","author":"Krivitzky","year":"2009","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107584_bb0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(18)30325-9","article-title":"Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study","volume":"18","author":"Lally","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107584_bb0220","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107584_bb0225","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/WNL.52.2.360","article-title":"Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis","volume":"52","author":"Lauronen","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107584_bb0230","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jnr.20123","article-title":"High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3","volume":"77","author":"Sitter","year":"2004","journal-title":"J. Neurosci. Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:53:12Z","timestamp":1761090792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1096719223002147"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107584","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain proton MR spectroscopy measurements in CLN3 disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107584"}}